Skip to main content
Mauna Kea Technologies logo

Mauna Kea Technologies — Investor Relations & Filings

Ticker · MKEA ISIN · FR0010609263 LEI · 5493007KMDG4MFIGJJ63 PA Manufacturing
Open in API
Filings indexed 774 across all filing types
Latest filing 2025-08-29 Share Issue/Capital Cha…
Country FR France
Listing PA MKEA

About Mauna Kea Technologies

https://www.maunakeatech.com/en/

Mauna Kea Technologies is a medical device company that develops and markets the Cellvizio® platform, a real-time in vivo cellular imaging system. The platform utilizes Confocal Laser Endomicroscopy (CLE) technology, enabling physicians to visualize tissue at the cellular level during medical procedures. This "optical biopsy" is performed using flexible, miniature fiber-optic probes (Confocal Miniprobes™) that are compatible with standard endoscopes. The core function of Cellvizio® is to provide immediate microscopic visualization, which aids in accelerating diagnosis, informing treatment strategies, and improving the precision of therapeutic interventions. Key applications include gastroenterology (for conditions such as Barrett's esophagus and pancreatic cysts), interventional pulmonology (lung cancer diagnostics), urologic oncology, and neurosurgery. The technology supports enhanced surgical procedures, including real-time margin assessment, and is being integrated with robotic surgery and AI-assisted imaging systems.

Recent filings

Filing Released Lang Actions
Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Share Issue/Capital Change Classification · 95% confidence The document is a monthly regulatory disclosure required by the AMF (French Financial Markets Authority) regarding the total number of voting rights and shares comprising the share capital. It provides a table of share counts and voting rights as of a specific date. This type of filing is a standard regulatory requirement for listed companies to keep the market informed of their capital structure and does not fit into specific categories like 'Share Issue' (which would be a specific event announcement) or 'Major Shareholding' (which would be a notification of a specific investor's stake). Therefore, it is classified as a general Regulatory Filing.
2025-08-29 English
Informations privilégiées / Information sur chiffre d’affaires annuel
Earnings Release Classification · 100% confidence The document is a press release from Mauna Kea Technologies announcing its financial results for the first half (S1) of 2025. It provides key highlights, revenue breakdowns by geography and category, and management commentary. It is not a full interim report (IR) but rather an initial announcement of the results, which fits the definition of an Earnings Release (ER). H1 2025
2025-07-28 French
Inside Information / Information on annual revenues
Earnings Release Classification · 100% confidence The document is a press release titled 'Mauna Kea Technologies Reports First Half 2025 Revenue'. It provides a summary of financial performance, including revenue figures, geographic breakdowns, and operational highlights for the first half of 2025. It is not a full interim report (which would be a longer, formal regulatory filing), but rather an initial announcement of financial results, which fits the definition of an Earnings Release (ER). H1 2025
2025-07-28 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 95% confidence The document is a press release from Mauna Kea Technologies announcing a new distribution partnership with Endotherapeutics to enter the Australian market. It details the strategic expansion, the nature of the agreement, and quotes from company leadership. It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor is it a report publication announcement (RPA) as it is the primary announcement itself. Therefore, it falls under the general regulatory filing/announcement category.
2025-07-24 French
Inside Information / Other news releases
Regulatory Filings Classification · 95% confidence The document is a press release issued by Mauna Kea Technologies announcing a new exclusive distribution partnership in Australia. It details the strategic expansion, the partner (Endotherapeutics), and the expected regulatory clearance. It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor is it a report publication announcement. As it is a general corporate announcement regarding business operations and market expansion, it falls under the 'Regulatory Filings' (RNS) category as the fallback for miscellaneous corporate announcements.
2025-07-24 English
Inside Information / Other news releases
Regulatory Filings Classification · 100% confidence The document is a press release dated July 21, 2025, announcing that Mauna Kea Technologies has been granted its 14th U.S. patent related to AI-based enhancement of Confocal Laser Endomicroscopy (CLE) image sequences. This announcement pertains to intellectual property (IP) and technological advancements, not routine financial reporting (like 10-K, ER, IR) or corporate governance events (like AGM, DEF 14A). Among the provided categories, 'IP' (Intellectual Property) is the most fitting classification for a patent grant announcement, even though 'IP' is not explicitly listed in the provided definitions. Since 'IP' is not an option, I must select the closest available category. The document is a specific announcement about a legal/proprietary asset (a patent). Given the options, 'LTR' (Legal Proceedings Report) is for lawsuits/regulatory actions, which is incorrect. 'RNS' (Regulatory Filings) is the general fallback for miscellaneous announcements. However, the core subject is the acquisition of a patent, which is a form of intellectual property protection. Since there is no specific 'IP' code, and this is a formal announcement about a specific corporate asset/development, 'RNS' (Regulatory Filings/General Announcement) is the most appropriate fallback, as it covers announcements that don't fit the primary financial or governance categories. Given the strong focus on the patent itself, if 'IP' were available, it would be chosen. Lacking 'IP', 'RNS' serves as the best general announcement category.
2025-07-21 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.